COMMUNIQUÉS West-GlobeNewswire

-
Palmetto GBA issues Draft Local Coverage Determination Expanding Guardant360 Medicare Coverage to Most Solid Tumor Types
28/03/2019 -
Merit Medical to Present at Needham Healthcare Conference
28/03/2019 -
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
28/03/2019 -
EHNAC Partners with National Accounting Firm Wipfli to Offer SOC 2 Compliance
28/03/2019 -
Predictive Technology Group Announces Lab Expansion and New Research and Development Facility for Subsidiary, Predictive Biotech
28/03/2019 -
Alphatec Announces Commercial Launch of its First IdentiTi™ Porous Titanium Interbody System
28/03/2019 -
Phoenix Life Sciences International Announces Dr. Santus Wari as Company's National Head of Healthcare in the Republic of Vanuatu
28/03/2019 -
Tauriga Sciences Inc. to Present at the ThinkEquity Conference on May 2, 2019 at the Mandarin Oriental Hotel in Manhattan
28/03/2019 -
Fluidigm Showcases New Product Innovations and Research Presentations at the 2019 American Association for Cancer Research (AACR) Meeting
28/03/2019 -
Teladoc Health Launches Telemedicine Service in Canada, Expanding Portfolio of Available Healthcare Solutions
28/03/2019 -
Teladoc Health lance un service de télémédecine au Canada, élargissant son portefeuille actuel de solutions de soins de santé
28/03/2019 -
Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences
28/03/2019 -
Nemaura CEO Provides Update to Shareholders
28/03/2019 -
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
28/03/2019 -
ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors
28/03/2019 -
Canntab Therapeutics Announces Engagement of Relations Publiques Paradox Inc. for Investor Relations Services
28/03/2019 -
Assure Holdings Selects New Billing and Collections Vendor
28/03/2019 -
Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry
28/03/2019 -
Innovation Pharmaceuticals European Subsidiary, IPIX Pharma Ltd., Granted Meeting with European Medicines Agency (EMA) to Discuss International Phase 3 Brilacidin Oral Mucositis Program
28/03/2019
Pages